Blumenthal, Roger - Johns Hopkins University

个人简介

Dr. Blumenthal's principal clinical and research interests involve the optimal management of ischemic heart disease, noninvasive detection of coronary atherosclerosis, and the development of new strategies to optimize the management of cardiovascular disease risk factors. Dr. Blumenthal specializes in treating adults who are at higher risk for future cardiovascular events because of 1) a history of prior cardiovascular or peripheral arterial disease or 2) the presence of multiple coronary risk factors. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, and he is the Director of Preventive Cardiology at Johns Hopkins. He is a member of the official national spokesperson panel for the American Heart Association (A.H.A.). Dr. Blumenthal is co-chair of the Prevention Subcommittee and was also chairman for four years of the American College of Cardiology (ACC) Committee for the prevention of cardiovascular disease. His co-chair role of the ACC/AHA Guideline Committee is updating the blood pressure, cholesterol, lifestyle and risk assessment guidelines. An experienced writer, Dr. Blumenthal is on the editorial board of The American Heart Journal, Clinical Cardiology and the American College of Cardiology Extended Learning Center (ACCEL). He is the Preventive Cardiology/Coronary Heart Disease section editor of Cardiology Today. He is editor of the annual Johns Hopkins White Paper on Prevention of Heart Disease/and co-editor of the textbook Preventive Cardiology: A companion to Braunwalds’s Heart Disease. He is also co-editor of the American Society of Preventive Cardiology (ASPC) Manual of Preventive Cardiology MD, Cornell University Medical College (1985)

研究领域

Cardiovascular Risk Assessment; Heart Disease in Women; Subclinical coronary atherosclerosis as measured by Cardiac CT; Hyperlipidemia; Primary and secondary prevention of coronary heart disease; Cardiac Computed Tomography; Individuals with a family history of heart disease; Improved strategies for management of cardiovascular risk factors

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Gluckman TJ, Sachdev M, Schulman SP, Blumenthal RS. A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA. 2005; 293:349-357. 2. Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced Risk Assessment in Asymptomatic Individuals Using Exercise Testing and Framingham Risk Scores. Circulation. 2005;112:1566-72. 3. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS. Framingham Risk Equation Underestimates Subclinical Atherosclerosis Risk in Asymptomatic Women. Atherosclerosis. 2006; 184:201-206. 4. Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, Szklo M, Greenland P, Blumenthal RS. Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;116:619-26. 5. Blumenthal RS, Michos ED, Nasir K. Further Improvements in CHD Risk Prediction for Women. JAMA. 2007; 297:641-3. 6. Lakoski SG, Greenland PG, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS. Coronary Artery Calcium Scores and Risk for Cardiovascular Events in Women Classified as Low Risk Based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2007;167:2437-2442. 7. Michos ED, Blumenthal RS. Prevalence of Low Low-Density Lipoprotein Cholesterol with Elevated High-Sensitivity C-reactive Protein in the U.S.- Implications of the JUPITER Study. J Am Coll Cardiol. 2009; 53:931-5. 8. Blumenthal RS, Michos ED. The HALTS Trial Halting Atherosclerosis or Halted Too Early? N Engl J Med. 2009; 361:2178-90. 9. Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, Shea S, Limia JAC, Blumenthal RS. Cardiovascular Events with Absent or Minimal Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009; 158:554-61. 10. Weiss SA, Blumenthal RS, Sharrett AR, Redberg RF, Mora S. Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals. Circulation. 2010; 121: 2109-16. 11. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for Cardiovascular Risk in Asymptomatic Patients. J Am Coll Cardiol. 2010; 55:1169-72. 12. Silverman MG, Blaha MJ, Blumenthal RS. Adjunctive Lipid Lowering Therapy in the Era of Surrogate Endpoints. Cardiol Rev. 2011;17-22. 13. Blankstein R, Budoff MJ, Shaw LJ, Goff DC, Polak JF, Lima J, Blumenthal RS, Nasir K. Predictors of Coronary Heart Disease Events Among Asymptomatic Individuals with Low LDL Cholesterol; MESA. J Am Coll Cardiol. 2011; 58:364-74. 14. Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, OLeary DH, Lima J, Blumenthal RS, Nasir K. Associations Between C-Reactive Protein, Coronary Artery Calcium, and Cardiovascular Events, and Implications for the JUPITER Population in MESA: A Population-Based Cohort Study. Lancet. 2011;378:684-92. 15. Blaha MJ, Blumenthal RS, Budoff MJ, Nasir K. Understanding the Utility of Zero Coronary Calcium As a Prognostic Test: A Bayesian Approach. Circ Cardiovasc Qual Outcomes. 2011;4:253-6. 16. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of Physical Activity on Cardiovascular Disease. Am J Cardiol. 2012;109:288-95. 17. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based Use of Statins For Primary Prevention of Cardiovascular Disease. Am J Med. 2012;125:440-6. 18. Blaha MJ, Nasir K, Blumenthal RS. Statin Therapy for Healthy Men Identified as Increased Risk. JAMA. 2012;307:1489-90. 19. Michos ED, Sibley CT, Baer JT, Blaha MJ, Blumenthal RS. Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events: Reconciling the AIM-HIGH Trial with Previous Surrogate Endpoint Trials. J Am Coll Cardiol. 2012;59:2058-64. 20. Martin, SS, Blaha MJ, Elshazly M, Brinton EA, Toth PP, McEvoy JW, Joshi PH, Kulkarni KR, Mize PD, Kwiterovich PO, DeFilipis AP, Blumenthal RS and Jones SR. Friedewald Estimated versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications Journal of the American College of Cardiology. 2013; 62(8):732-9. 21. Ahmed HM, Blaha MJ, Nasir K, Jones SR, Rivera JJ, Agatston A, Blankstein R, Wong ND, Lakoski S, Budoff MJ, Burke GL, Sibley CT, Ouyang P, Blumenthal RS. Low-Risk Lifestyle, Coronary Calcium, Cardiovascular Events, and Mortality: Results From MESA. American Journal of Epidemiology 2013; 1:178(1):12-21. 22. Martin SS, Blaha MJ, Blankstein R, Agatston A, Rivera JJ, Virani SS, Ouyang P, Jones SR, Blumenthal RS, Budoff MJ, Nasir K. Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular Disease: Implications for Statin Therapy from the Multi-Ethnic Study of Atherosclerosis. Circulation. 2014; 129:77-86. 23. Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a Novel Method vs the Friedewald Equation for Estimating LDL-Cholesterol Levels from the Standard Lipid Profile. Journal American Medical Association. 2013; 310(19):2061-8. 24. Silverman MG, Blaha MJ, Krumholz HM, Budoff MJ, Blankstein R, Sibley CT, Agatston A, Blumenthal RS, Nasir K. Impact of Coronary Artery Calcium on Coronary Heart Disease Events in Individuals at the Extremes of Traditional Risk Factor Burden: the Multi-Ethnic Study of Atherosclerosis. European Heart Journal. 2014; 35(33):2232-41.